G1 Therapeutics
Utility Patent Applications
Last updated:
List of all G1 Therapeutics patents 26 in total
| Status | Patent |
|---|---|
Application | Utility: TARGETED TREATMENT OF CANCERS WITH DYSREGULATED FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING Filling date: 26 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: PATIENT SELECTION FOR ENHANCEMENT OF ANTI-TUMOR IMMUNITY IN CANCER PATIENTS Filling date: 26 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN COMBINATION WITH CYCLIN DEPENDENT KINASE 4/6 INHIBITORS Filling date: 26 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: CDK INHIBITORS Filling date: 26 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF Filling date: 26 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY Filling date: 26 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: THERAPEUTIC REGIMENS FOR TREATMENT OF CANCER USING ERIBULIN AND SELECTIVE CDK4/6 INHIBITOR COMBINATIONS Filling date: 26 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERATION Filling date: 26 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: SYNTHESIS OF 1,4-DIAZASPIRO[5.5]UNDECAN-3-ONE Filling date: 26 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS Filling date: 26 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINES Filling date: 26 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGAINST IONIZING RADIATION Filling date: 26 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: PYRIMIDINE-BASED ANTIPROLIFERATIVE AGENTS Filling date: 26 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: TREATMENT OF CANCERS HAVING DRIVING ONCOGENIC MUTATIONS Filling date: 26 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: G1T38 SUPERIOR DOSAGE REGIMES Filling date: 26 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS Filling date: 26 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY Filling date: 26 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ABNORMAL CELLULAR PROLIFERATION Filling date: 26 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: ANTIPROLIFERATIVE PYRIMIDINE-BASED COMPOUNDS Filling date: 26 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: CDK INHIBITORS Filling date: 26 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: PYRIMIDINE-BASED COMPOUNDS FOR THE TREATMENT OF CANCER Filling date: 26 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS Filling date: 26 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN COMBINATION WITH CYCLIN DEPENDENT KINASE 4/6 INHIBITORS Filling date: 26 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: TREATMENT OF EGFR-DRIVEN CANCER WITH FEWER SIDE EFFECTS Filling date: 26 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: COMBINATION THERAPY FOR TREATMENT OF CANCER Filling date: 26 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: PRESERVATION OF IMMUNE RESPONSE DURING CHEMOTHERAPY REGIMENS Filling date: 26 Sep 2025 Issue date: 24 Oct 2019 |
Showing 1 to 26 of 26 patents.